Amarex Clinical Research   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Germantown MD United States (1998)

Organization Overview

First Clinical Trial
2011
NCT01421966
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Amarex Clinical Research | Amarex Clinical Research, LLC (Amarex)